Small Molecule Drug Discovery for Neglected Tropical Snakebite

Area of Science:

• Toxicology
• Pharmacology
• Tropical Medicine

Background:

• Snakebite envenoming is a neglected tropical disease (NTD) causing significant annual mortality.
• Current biologic antivenoms are often poorly effective, require intravenous administration, and are costly.
• There is a critical need for improved and accessible snakebite treatments.

Purpose of the Study:

• To outline challenges in developing novel snakebite therapies.
• To explore the potential of small molecule drugs targeting venom toxins.
• To identify strategies for advancing next-generation snakebite treatments.

Main Methods:

• Review of challenges in drug discovery and development for snakebite.
• Analysis of the therapeutic potential of small molecule inhibitors.
• Examination of successful strategies from other NTDs.

Main Results:

• Small molecule drugs offer a promising avenue for snakebite treatment development.
• Overcoming challenges in drug development is crucial for efficacy.
• Existing strategies for other NTDs can be adapted for snakebite therapies.

Conclusions:

• Next-generation snakebite treatments are needed to address the limitations of current antivenoms.
• Small molecule drugs targeting venom toxins represent a viable therapeutic strategy.
• Leveraging successful approaches from other NTDs can accelerate the development of improved snakebite treatments.